BioSpace News Archive

PRINCETON, N.J., Nov. 27, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS) (the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced the closing of an underwritten public offering of 26,666,666 shares of common stock and warrants to purchase up to 13,333,333 shares of common stock, along with an additional 3,999,999 shares of common stock and 1,999,999 warrants pursuant to the full exercise of the

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on November 25, 2020, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 18,000 shares, and restricted stock units for an aggregate of 70,200 s

oday marked the launch of the WestJet-YVR COVID-19 Testing Study, a collaborative effort between researchers from UBC and Providence Health Care and project sponsors WestJet and Vancouver Airport Authority.

The Government of Canada has officially launched the Canadian Food Safety Information Network (CFSIN) , a new food safety platform that will help food safety experts from across the country work together to better anticipate, detect and respond to food safety issues and foodborne illness incidents. The newly up and running network is